Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells

EBioMedicine

Volumn 23, Issue , 2017, Pages 34-45

  Takahashi, Yu ^a,b   Sato, Shintaro ^a,c   Kurashima, Yosuke ^a,d   Lai, Chen Yi ^a   Otsu, Makoto ^a   Hayashi, Mikio ^b   Yamaguchi, Takayuki ^b   Kiyono, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN TOBACCO INC   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Adipocytes; Co culture; Crohn's disease; Induced pluripotent stem cells; Intestinal epithelial cells; Organoids

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCULTURE; COLON TISSUE; CROHN DISEASE; CYTOPLASM; ENTEROCOLITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTRAPERITONEAL FAT; MESENTERIC FAT; MOUSE; NONHUMAN; OBESITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CELL LINE; CYTOLOGY; DISEASE MODEL; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; INDUCED PLURIPOTENT STEM CELL; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 85026809085     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2017.07.027     Document Type: Article

References (57)

1. Annese, V., Rogai, F., Settesoldi, A., Bagnoli, S., PPARgamma in inflammatory bowel disease. PPAR Res., 2012, 2012, 620839, 10.1155/2012/620839.
2. Artursson, P., Ungell, A.L., Lofroth, J.E., Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res. 10 (1993), 1123–1129.
3. Bertin, B., Desreumaux, P., Dubuquoy, L., Obesity, visceral fat and Crohn's disease. Curr. Opin. Clin. Nutr. Metab. Care 13 (2010), 574–580, 10.1097/MCO.0b013e32833cf0f4.
4. Bouloumie, A., Sengenes, C., Portolan, G., Galitzky, J., Lafontan, M., Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50 (2001), 2080–2086.
5. Boutros, M., Maron, D., Inflammatory bowel disease in the obese patient. Clin. Colon Rectal Surg. 24 (2011), 244–252, 10.1055/s-0031-1295687.
6. Cao, A.T., Yao, S., Gong, B., Elson, C.O., Cong, Y., Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J. Immunol. 189 (2012), 4666–4673, 10.4049/jimmunol.1200955.
7. Castaneda, F.E., Walia, B., Vijay-Kumar, M., Patel, N.R., Roser, S., Kolachala, V.L., Rojas, M., Wang, L., Oprea, G., Garg, P., Gewirtz, A.T., Roman, J., Merlin, D., Sitaraman, S.V., Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 129 (2005), 1991–2008, 10.1053/j.gastro.2005.09.017.
8. Chiarelli, F., Di Marzio, D., Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives. Vasc. Health Risk Manag. 4 (2008), 297–304.
9. Coffey, J.C., O'Leary, D.P., Kiernan, M.G., Faul, P., The mesentery in Crohn's disease: friend or foe?. Curr. Opin. Gastroenterol. 32 (2016), 267–273, 10.1097/mog.0000000000000280.
10. Desreumaux, P., Ernst, O., Geboes, K., Gambiez, L., Berrebi, D., Muller-Alouf, H., Hafraoui, S., Emilie, D., Ectors, N., Peuchmaur, M., Cortot, A., Capron, M., Auwerx, J., Colombel, J.F., Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 117 (1999), 73–81.
11. Ding, S., Lund, P.K., Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 14 (2011), 328–333, 10.1097/MCO.0b013e3283478727.
12. Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M., Magness, S., Jobin, C., Lund, P.K., High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One, 5, 2010, e12191, 10.1371/journal.pone.0012191.
13. Drouet, M., Dubuquoy, L., Desreumaux, P., Bertin, B., Visceral fat and gut inflammation. Nutrition 28 (2012), 113–117, 10.1016/j.nut.2011.09.009.
14. Dunmore, S.J., Brown, J.E., The role of adipokines in beta-cell failure of type 2 diabetes. J. Endocrinol. 216 (2013), T37–45, 10.1530/JOE-12-0278.
15. Fink, C., Karagiannides, I., Bakirtzi, K., Pothoulakis, C., Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm. Bowel Dis. 18 (2012), 1550–1557, 10.1002/ibd.22893.
16. Fruhbeck, G., Mendez-Gimenez, L., Fernandez-Formoso, J.A., Fernandez, S., Rodriguez, A., Regulation of adipocyte lipolysis. Nutr. Res. Rev. 27 (2014), 63–93, 10.1017/S095442241400002X.
17. Gan, X., Wong, B., Wright, S.D., Cai, T.Q., Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli. J. Interf. Cytokine Res. 21 (2001), 93–98, 10.1089/107999001750069953.
18. Ghadimi, B.M., Sackett, D.L., Difilippantonio, M.J., Schrock, E., Neumann, T., Jauho, A., Auer, G., Ried, T., Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosom. Cancer 27 (2000), 183–190.
19. Goncalves, P., Magro, F., Martel, F., Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm. Bowel Dis. 21 (2015), 453–467, 10.1097/mib.0000000000000209.
20. Graham, M.F., Diegelmann, R.F., Elson, C.O., Lindblad, W.J., Gotschalk, N., Gay, S., Gay, R., Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 94 (1988), 257–265.
21. Grasset, E., Pinto, M., Dussaulx, E., Zweibaum, A., Desjeux, J.F., Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters. Am. J. Phys. 247 (1984), C260–267.
22. Gulhane, M., Murray, L., Lourie, R., Tong, H., Sheng, Y.H., Wang, R., Kang, A., Schreiber, V., Wong, K.Y., Magor, G., Denman, S., Begun, J., Florin, T.H., Perkins, A., Cuiv, P.O., McGuckin, M.A., Hasnain, S.Z., High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Sci Rep, 6, 2016, 28990, 10.1038/srep28990.
23. Hodge, D.R., Hurt, E.M., Farrar, W.L., The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41 (2005), 2502–2512, 10.1016/j.ejca.2005.08.016.
24. Hosomi, S., Kaser, A., Blumberg, R.S., Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease. Curr. Opin. Gastroenterol. 31 (2015), 81–88, 10.1097/mog.0000000000000144.
25. Karagiannides, I., Kokkotou, E., Tansky, M., Tchkonia, T., Giorgadze, N., O'Brien, M., Leeman, S.E., Kirkland, J.L., Pothoulakis, C., Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 5207–5212, 10.1073/pnas.0600821103.
26. Kaser, A., Zeissig, S., Blumberg, R.S., Inflammatory bowel disease. Annu. Rev. Immunol. 28 (2010), 573–621, 10.1146/annurev-immunol-030409-101225.
27. Kersting, S., Bruewer, M., Schuermann, G., Klotz, A., Utech, M., Hansmerten, M., Krieglstein, C.F., Senninger, N., Schulzke, J.-D., Naim, H.Y., Zimmer, K.-P., Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases. Am. J. Pathol. 165 (2004), 425–437, 10.1016/s0002-9440(10)63308-1.
28. Kim, K.A., Kim, J.H., Wang, Y., Sul, H.S., Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol. Cell. Biol. 27 (2007), 2294–2308, 10.1128/mcb.02207-06.
29. de Luca, C., Olefsky, J.M., Inflammation and insulin resistance. FEBS Lett. 582 (2008), 97–105, 10.1016/j.febslet.2007.11.057.
30. McCracken, K.W., Howell, J.C., Wells, J.M., Spence, J.R., Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6 (2011), 1920–1928, 10.1038/nprot.2011.410.
31. Moon, C., VanDussen, K.L., Miyoshi, H., Stappenbeck, T.S., Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis. Mucosal Immunol., 2013, 10.1038/mi.2013.98.
32. Paik, J., Fierce, Y., Treuting, P.M., Brabb, T., Maggio-Price, L., High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a −/− male mice. J. Nutr. 143 (2013), 1240–1247, 10.3945/jn.113.174615.
33. Parks, W.C., Wilson, C.L., Lopez-Boado, Y.S., Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4 (2004), 617–629, 10.1038/nri1418.
34. Peterson, L.W., Artis, D., Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14 (2014), 141–153, 10.1038/nri3608.
35. Peyrin-Biroulet, L., Chamaillard, M., Gonzalez, F., Beclin, E., Decourcelle, C., Antunes, L., Gay, J., Neut, C., Colombel, J.F., Desreumaux, P., Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Gut 56 (2007), 577–583, 10.1136/gut.2005.082925.
36. Rosen, E.D., MacDougald, O.A., Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7 (2006), 885–896, 10.1038/nrm2066.
37. Rosen, E.D., Spiegelman, B.M., Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444 (2006), 847–853, 10.1038/nature05483.
38. Rousset, M., The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 68 (1986), 1035–1040.
39. Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van Es, J.H., Abo, A., Kujala, P., Peters, P.J., Clevers, H., Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459 (2009), 262–265, 10.1038/nature07935.
40. Sato, T., Stange, D.E., Ferrante, M., Vries, R.G., Van Es, J.H., Van den Brink, S., Van Houdt, W.J., Pronk, A., Van Gorp, J., Siersema, P.D., Clevers, H., Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 141 (2011), 1762–1772, 10.1053/j.gastro.2011.07.050.
41. Speca, S., Giusti, I., Rieder, F., Latella, G., Cellular and molecular mechanisms of intestinal fibrosis. World J. Gastroenterol. 18 (2012), 3635–3661, 10.3748/wjg.v18.i28.3635.
42. Spence, J.R., Mayhew, C.N., Rankin, S.A., Kuhar, M.F., Vallance, J.E., Tolle, K., Hoskins, E.E., Kalinichenko, V.V., Wells, S.I., Zorn, A.M., Shroyer, N.F., Wells, J.M., Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470 (2011), 105–109, 10.1038/nature09691.
43. Steed, H., Walsh, S., Reynolds, N., A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland. Obes. Facts 2 (2009), 370–372, 10.1159/000262276.
44. Suganami, T., Nishida, J., Ogawa, Y., A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 2062–2068, 10.1161/01.ATV.0000183883.72263.13.
45. Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai, S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., Kamei, Y., Ogawa, Y., Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 84–91, 10.1161/01.ATV.0000251608.09329.9a.
46. Takahashi, Y., Ohoka, N., Hayashi, H., Sato, R., TRB3 suppresses adipocyte differentiation by negatively regulating PPARgamma transcriptional activity. J. Lipid Res. 49 (2008), 880–892, 10.1194/jlr.M700545-JLR200.
47. Takahashi, Y., Shinoda, A., Kamada, H., Shimizu, M., Inoue, J., Sato, R., Perilipin2 plays a positive role in adipocytes during lipolysis by escaping proteasomal degradation. Sci Rep, 6, 2016, 20975, 10.1038/srep20975.
48. Takayama, N., Nishimura, S., Nakamura, S., Shimizu, T., Ohnishi, R., Endo, H., Yamaguchi, T., Otsu, M., Nishimura, K., Nakanishi, M., Sawaguchi, A., Nagai, R., Takahashi, K., Yamanaka, S., Nakauchi, H., Eto, K., Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J. Exp. Med. 207 (2010), 2817–2830, 10.1084/jem.20100844.
49. Teixeira, L.G., Leonel, A.J., Aguilar, E.C., Batista, N.V., Alves, A.C., Coimbra, C.C., Ferreira, A.V., de Faria, A.M., Cara, D.C., Alvarez Leite, J.I., The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation. Lipids Health Dis., 10, 2011, 204, 10.1186/1476-511x-10-204.
50. VanDussen, K.L., Marinshaw, J.M., Shaikh, N., Miyoshi, H., Moon, C., Tarr, P.I., Ciorba, M.A., Stappenbeck, T.S., Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 64 (2015), 911–920, 10.1136/gutjnl-2013-306651.
51. Wang, Y., Srinivasan, K., Siddiqui, M.R., George, S.P., Tomar, A., Khurana, S., A novel role for villin in intestinal epithelial cell survival and homeostasis. J. Biol. Chem. 283 (2008), 9454–9464, 10.1074/jbc.M707962200.
52. Wang, X., Yamamoto, Y., Wilson, L.H., Zhang, T., Howitt, B.E., Farrow, M.A., Kern, F., Ning, G., Hong, Y., Khor, C.C., Chevalier, B., Bertrand, D., Wu, L., Nagarajan, N., Sylvester, F.A., Hyams, J.S., Devers, T., Bronson, R., Lacy, D.B., Ho, K.Y., Crum, C.P., McKeon, F., Xian, W., Cloning and variation of ground state intestinal stem cells. Nature 522 (2015), 173–178, 10.1038/nature14484.
53. Williams, B.B., Tebbutt, N.C., Buchert, M., Putoczki, T.L., Doggett, K., Bao, S., Johnstone, C.N., Masson, F., Hollande, F., Burgess, A.W., Scott, A.M., Ernst, M., Heath, J.K., Glycoprotein A33 deficiency: a new mouse model of impaired intestinal epithelial barrier function and inflammatory disease. Dis. Model. Mech. 8 (2015), 805–815, 10.1242/dmm.019935.
54. Yui, S., Nakamura, T., Sato, T., Nemoto, Y., Mizutani, T., Zheng, X., Ichinose, S., Nagaishi, T., Okamoto, R., Tsuchiya, K., Clevers, H., Watanabe, M., Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5 + stem cell. Nat. Med. 18 (2012), 618–623, 10.1038/nm.2695.
55. Zeissig, S., Bojarski, C., Buergel, N., Mankertz, J., Zeitz, M., Fromm, M., Schulzke, J.D., Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 53 (2004), 1295–1302, 10.1136/gut.2003.036632.
56. Zhang, R.R., Lam, Y.Y., Ha, C.W.Y., Campbell, C.R., Mitchell, A.J., Dinudom, A., Oscarsson, J., Cook, D.I., Hunt, N.H., Caterson, I.D., Holmes, A.J., Storlien, L.H., Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One, 7, 2012, e34233, 10.1371/journal.pone.0034233.
57. Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., Abbas, A.R., Modrusan, Z., Ghilardi, N., de Sauvage, F.J., Ouyang, W., Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14 (2008), 282–289, 10.1038/nm1720.